GSA Capital Partners’s Monte Rosa Therapeutics GLUE Stock Holding History

GSA Capital Partners’s Portfolio GLUE Stock Details GLUE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$204K	Sell
2025 Q3	$989K	Sell
2025 Q2	$1.28M	Buy
2025 Q1	$70K	Buy
2024 Q3	–	Sell
2024 Q2	$95K	Buy
2022 Q4	–	Sell
2022 Q3	$156K	Buy